Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
AnPac Bio-Medical Science Co. Ltd is a biotechnology business based in the US. AnPac Bio-Medical Science CoLtd shares (ANPC) are listed on the NASDAQ and all prices are listed in US Dollars. AnPac Bio-Medical Science CoLtd employs 86 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Guided Investing
Our top pick for
Experienced Investors
| Latest market close | $2.88 |
|---|---|
| 52-week range | $2.84 - $8.20 |
| 50-day moving average | $3.43 |
| 200-day moving average | $4.29 |
| Wall St. target price | $8.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.19 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.88 from 2021-10-15
| 1 week (2021-10-08) | -2.04% |
|---|---|
| 1 month (2021-09-16) | -15.54% |
| 3 months (2021-07-16) | -31.75% |
| 6 months (2021-04-16) | -42.40% |
| 1 year (2020-10-16) | -17.71% |
|---|---|
| 2 years (2019-10-12) | N/A |
| 3 years (2018-10-12) | N/A |
| 5 years (2016-10-12) | N/A |
| Revenue TTM | $21.8 million |
|---|---|
| Gross profit TTM | $12.9 million |
| Return on assets TTM | -99.54% |
| Return on equity TTM | -530.19% |
| Profit margin | 0% |
| Book value | $0.58 |
| Market capitalisation | $41.5 million |
TTM: trailing 12 months
There are currently 32,676 AnPac Bio-Medical Science CoLtd shares held short by investors – that's known as AnPac Bio-Medical Science CoLtd's "short interest". This figure is 18.6% down from 40,148 last month.
There are a few different ways that this level of interest in shorting AnPac Bio-Medical Science CoLtd shares can be evaluated.
AnPac Bio-Medical Science CoLtd's "short interest ratio" (SIR) is the quantity of AnPac Bio-Medical Science CoLtd shares currently shorted divided by the average quantity of AnPac Bio-Medical Science CoLtd shares traded daily (recently around 58350). AnPac Bio-Medical Science CoLtd's SIR currently stands at 0.56. In other words for every 100,000 AnPac Bio-Medical Science CoLtd shares traded daily on the market, roughly 560 shares are currently held short.
To gain some more context, you can compare AnPac Bio-Medical Science CoLtd's short interest ratio against those of similar companies.
However AnPac Bio-Medical Science CoLtd's short interest can also be evaluated against the total number of AnPac Bio-Medical Science CoLtd shares, or, against the total number of tradable AnPac Bio-Medical Science CoLtd shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AnPac Bio-Medical Science CoLtd's short interest could be expressed as 0% of the outstanding shares (for every 100,000 AnPac Bio-Medical Science CoLtd shares in existence, roughly 0 shares are currently held short) or 0.0044% of the tradable shares (for every 100,000 tradable AnPac Bio-Medical Science CoLtd shares, roughly 4 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AnPac Bio-Medical Science CoLtd.
Find out more about how you can short AnPac Bio-Medical Science CoLtd stock.
We're not expecting AnPac Bio-Medical Science CoLtd to pay a dividend over the next 12 months.
You may also wish to consider:
AnPac Bio-Medical Science Co. , Ltd. , a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China. It offers cancer differentiation analysis devices and physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China. .
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
